Global Animal Model for Drug Testing Market Research Report 2024(Status and Outlook)

Report Overview:

 Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.

 Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.

Market Value:

 The Global Animal Model for Drug Testing Market Size was estimated at USD 2501.27 million in 2023 and is projected to reach USD 3429.29 million by 2029, exhibiting a CAGR of 5.40% during the forecast period.

CAGR of 5.40% (2022 – 2029)

By Types: •Rats

Mice

Others

Applications:

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Key players include:

• Charles River Laboratories

• Envigo

• Taconic Biosciences

• Jackson Laboratory

• Crown Biosciences

• Shanghai SLAC

• Shangghai Modelorg

• GenOway

• Syngene International